Besides, CCR7 overexpressed and antigen modificatory DCs also show greater migratory ability to dLNs and more valid anti-tumor properties in melanoma and lung cancer (Okada et al., 2005; Salem et al., 2021). The gene discussed is CCR7; the disease is melanoma.